Home/Filings/4/0001513160-11-000062
4//SEC Filing

Schroeder Martin 4

Accession 0001513160-11-000062

CIK 0001425205other

Filed

Sep 29, 8:00 PM ET

Accepted

Sep 30, 3:25 PM ET

Size

5.0 KB

Accession

0001513160-11-000062

Insider Transaction Report

Form 4
Period: 2011-08-22
Transactions
  • Award

    Common Stock

    2011-08-22$1.13/sh+1,000,000$1,130,0001,000,000 total(indirect: By LLC)
Footnotes (2)
  • [F1]Shares were granted for services rendered to the Company.
  • [F2]Mr. Schroeder is Executive Vice President and Managing Director of the Emmes Group, Inc., a strategic business consulting firm.

Issuer

Genesis Biopharma, Inc

CIK 0001425205

Entity typeother

Related Parties

1
  • filerCIK 0001412295

Filing Metadata

Form type
4
Filed
Sep 29, 8:00 PM ET
Accepted
Sep 30, 3:25 PM ET
Size
5.0 KB